Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma.

Jamin, Yann; Tucker, Elizabeth R; Poon, Evon; Popov, Sergey; Vaughan, Lynsey; Boult, Jessica K R; Webber, Hannah; Hallsworth, Albert; Baker, Lauren C J; Jones, Chris; Koh, Dow-Mu; Pearson, Andrew D J; Chesler, Louis; Robinson, Simon P

Jamin, Yann; Tucker, Elizabeth R; Poon, Evon; Popov, Sergey; Vaughan, Lynsey; Boult, Jessica K R; Webber, Hannah; Hallsworth, Albert; Baker, Lauren C J; Jones, Chris; Koh, Dow-Mu; Pearson, Andrew D J; Chesler, Louis; Robinson, Simon P.

Affiliation

Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, Surrey SM2 5NG, England. Yann.Jamin@icr.ac.uk

Radiology ; 266(1): 130-40, 2013 Jan.

Article in En | MEDLINE | ID: mdl-23169794

Subject(s)

Antineoplastic Agents/therapeutic use; Disease Models, Animal; Neuroblastoma/drug therapy; Neuroblastoma/pathology; Animals; Biomarkers; Humans; Magnetic Resonance Imaging; Mice; Mice, Transgenic; N-Myc Proto-Oncogene Protein; Prognosis; Proto-Oncogene Proteins/genetics; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Disease Models, Animal / Neuroblastoma / Antineoplastic Agents Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Radiology Year: 2013 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google